Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis

Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis

Abstract Background Live birth has increasingly been identified as the standard clinical approach to measure the success of medically assisted reproduction (MAR). However, previous analyses comparing biosimilar preparations of follitropin alfa versus the reference product (GONAL-f®, Merck KGaA, Darm...

Full description

Bibliographic Details
Main Authors: Su Jen Chua, Ben W. Mol, Salvatore Longobardi, Raoul Orvieto, Christos A. Venetis, Monica Lispi, Ashleigh Storr, Thomas D’Hooghe
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Reproductive Biology and Endocrinology
Subjects:
Biosimilar
Follitropin alfa
IVF
Ovarian stimulation
r-hFSH
Online Access:https://doi.org/10.1186/s12958-021-00727-y

Internet

https://doi.org/10.1186/s12958-021-00727-y

Similar Items